Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Addeo

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Translational Lung Cancer Research|August 12, 2022
From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancerGiuseppe Luigi Banna, Jarushka Naidoo, Alfredo Addeo
JAMA Oncology|January 24, 2017
Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?Alfredo Addeo, Lucio Buffoni, Massimo Di Maio
BMJ Evidence-Based Medicine|July 11, 2020
Is clinical effectiveness in the eye of the beholder during the COVID-19 pandemic?José Luis Sandoval, Alex Friedlaender, Alfredo Addeo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Filtering Data About Treatment-Induced Renal Injury: From Biology to PracticeAlfredo Addeo, Luigi Giuseppe Banna, Alex Friedlaender
Translational Lung Cancer Research|March 14, 2022
One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancerAlfredo Addeo, Alessio Cortellini, Giuseppe Luigi Banna
Cancers|June 2, 2021
KRAS G12C Mutations in NSCLC: From Target to ResistanceAlfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Lung Cancer Research|August 14, 2023
Tarlatamab: a potential new option for recurrent small cell lung cancerAlfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
JAMA Network Open|May 11, 2019
Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled AnalysisAlfredo Addeo, Glen J Weiss, Bishal Gyawali
Revue Medicale Suisse|May 17, 2024
Solange Peters, Alfredo Addeo, Fernanda Gabriela Herrera
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
Management of stage III non-small-cell lung cancer: rays of hopeFloryane Kim, Maxime Borgeaud, Alfredo Addeo, et al.
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Translational Lung Cancer Research|August 12, 2022
From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancerGiuseppe Luigi Banna, Jarushka Naidoo, Alfredo Addeo
JAMA Oncology|January 24, 2017
Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?Alfredo Addeo, Lucio Buffoni, Massimo Di Maio
BMJ Evidence-Based Medicine|July 11, 2020
Is clinical effectiveness in the eye of the beholder during the COVID-19 pandemic?José Luis Sandoval, Alex Friedlaender, Alfredo Addeo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Filtering Data About Treatment-Induced Renal Injury: From Biology to PracticeAlfredo Addeo, Luigi Giuseppe Banna, Alex Friedlaender
Translational Lung Cancer Research|March 14, 2022
One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancerAlfredo Addeo, Alessio Cortellini, Giuseppe Luigi Banna
Cancers|June 2, 2021
KRAS G12C Mutations in NSCLC: From Target to ResistanceAlfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Translational Lung Cancer Research|August 14, 2023
Tarlatamab: a potential new option for recurrent small cell lung cancerAlfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
JAMA Network Open|May 11, 2019
Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled AnalysisAlfredo Addeo, Glen J Weiss, Bishal Gyawali
Revue Medicale Suisse|May 17, 2024
Solange Peters, Alfredo Addeo, Fernanda Gabriela Herrera
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
Management of stage III non-small-cell lung cancer: rays of hopeFloryane Kim, Maxime Borgeaud, Alfredo Addeo, et al.
Pageof 23